Skip to content

Scailyte Quarterly Update, January 2021

Scailyte™ and ScaiVision™ are registered trademarks proprietary to Scailyte AG.

Recent News

Scailyte Quarterly Update, April 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

Recent News

Scailyte and Volv Global announce strategic partnership to accelerate rare disease patient diagnosis

Two Artificial Intelligence (AI)-driven biomarker discovery companies Scailyte and Volv Global today

Read more

Recent News

Scailyte Quarterly Update, January 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

ScaiVision® performs best-in-class at sample class prediction!

ScaiVision® v1.0.0 was released internally and benchmarked in a massive experiment, outperforming a

Read more

Recent News

Scailyte participates @ swissnex san francisco DEMO DAY!

Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day

Read more

Recent News

03 /04

Scailyte and Volv Global announce strategic partnership to accelerate rare disease patient diagnosis

Two Artificial Intelligence (AI)-driven biomarker discovery companies Scailyte and Volv Global today

Read more

Scailyte Quarterly Update, January 2021

Quarterly update on Scailyte's progress towards its mission to save millions of lives.

Read more

Recent News

04 /04

ScaiVision® performs best-in-class at sample class prediction!

ScaiVision® v1.0.0 was released internally and benchmarked in a massive experiment, outperforming a

Read more

Scailyte participates @ swissnex san francisco DEMO DAY!

Striving to internationalize and network, Scailyte participates and pitches at the swissnex Demo Day

Read more

Recent News